Monday | Dec 23 2024 |
NaMuscla is the first and only approved treatment in Europe for these rare neuromuscular disorders, which are characterised by the inability of muscles to relax after voluntary contractions, leading to muscle stiffness (myotonia)
Subscribe to our newsletter to get updates on our latest news
